Colorado's Medical Marijuana Market Takes Another Big Hit

For the third consecutive quarter, The Colorado Department of Revenue posted neg comps for cannabis both YoY and QoQ. Q1:22 results -41% med / -13% rec YoY and -23% med / -11% rec QoQ. The deceleration in revenue growth is consistent with what we have observed for the past 3 quarters from many of the MSOs and other states but was compounded by new regulations that went into effect Jan 1 limiting daily marijuana purchases.

captura_de_pantalla_2022-06-23_125512.png

 

In March 2020, and on a few other occasions, we expressed concern that disposable income levels could fall …

Full story available on Benzinga.com

More Colorado's Medical Marijuana Market Takes Another Big Hit